Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Mei Su

Mei Su publishes mostly in Organic Chemistry, Molecular Biology and Oncology, on topics such as Cytokine Signaling Pathways and Interactions, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chemical Synthesis and Reactions.

OpenAlex
World rank
#3,405,666
of 7,710,434 ranked researchers
Rank in China
#534,551
of 978,568
Works
52
Citations
968
Citations per work
18.6
h-index
18
i10-index 25Top 27% in Organic Chemistry
Mei Su

What does Mei Su research?

Mei Su's work is mostly in Chemistry (20%), Medicine (18%), Biochemistry, Genetics and Molecular Biology (12%).

Everything else: 24 works · 45.6% of their workPhysical Sciences: 12 works · 23.6% of their workChemistry: 10 works · 19.7% of their workOrganic Chemistry: 10 works · 19.7% of their workEngineering: 2 works · 3.9% of their workBiomedical Engineering: 2 works · 3.9% of their workHealth Sciences: 10 works · 18.3% of their workMedicine: 10 works · 18.3% of their workOncology: 5 works · 10.5% of their workComplementary and alternative medicine: 2 works · 3.9% of their workGenetics: 2 works · 3.9% of their workLife Sciences: 6 works · 12.5% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 12.5% of their workMolecular Biology: 6 works · 12.5% of their workTHEIR WORKMei Su52works
Life Sciences12%Physical Sciences24%Health Sciences18%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else2445.6%
    1. Chemistry1019.7%
    2. Engineering23.9%
    1. Medicine1018.3%
    1. Biochemistry, Genetics and Molecular Biology612.5%
  1. 1Organic Chemistry20% of their works
  2. 2Molecular Biology12% of their works
  3. 3Oncology10% of their works
  4. 4Genetics4% of their works
  5. 5Biomedical Engineering4% of their works
  6. 6Complementary and alternative medicine4% of their works

Research topics

Which keywords describe Mei Su's research?

The keywords of their largest research topics: Cancer, Chemoselective, IL-6, STAT3, JAK2 Mutation, Myelofibrosis, Catalysis and Oxidation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer112 topics
  2. Chemoselective82 topics
  3. IL-681 topic
  4. STAT381 topic
  5. JAK2 Mutation61 topic
  6. Myelofibrosis61 topic
  7. Catalysis41 topic
  8. Oxidation41 topic
  9. Thioamides41 topic
  10. Thionation41 topic
  11. DNA31 topic
  12. DNA Damage31 topic
  13. Enantioselective Reactions31 topic
  14. IL-1731 topic
  15. Organocatalysis31 topic
  16. Repair31 topic
  17. TH17 Cells31 topic
  18. Topoisomerases31 topic

Where does Mei Su work?

Mei Su's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Mei Su have?

OpenAlex counts 52 works and 968 citations for Mei Su, an h-index of 18, ranking #3,405,666 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Mei Su

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mei Su. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.